215 related articles for article (PubMed ID: 17242576)
1. FDG PET/CT for assessing therapy response in primary thyroid lymphoma.
Lin EC
Clin Nucl Med; 2007 Feb; 32(2):152-3. PubMed ID: 17242576
[No Abstract] [Full Text] [Related]
2. Residual FDG uptake of primary thyroid lymphoma after treatment may overestimate residual lymphoma.
Fujii H; Nakadate M; Tanaka H; Harata N; Oota S; Isogai J; Yoshida K
Ann Nucl Med; 2016 Dec; 30(10):756-759. PubMed ID: 27614754
[TBL] [Abstract][Full Text] [Related]
3. Fluorodeoxyglucose positron emission tomography in primary thyroid lymphoma with coexisting lymphocytic thyroiditis.
Arabi M; Dvorak R; Smith LB; Kujawski L; Gross MD
Thyroid; 2011 Oct; 21(10):1153-6. PubMed ID: 21875367
[TBL] [Abstract][Full Text] [Related]
4. Focal thyroid incidentaloma on whole body fluorodeoxyglucose positron emission tomography/computed tomography in known cancer patients: A case-based discussion with a series of three examples.
Targe M; Basu S
J Cancer Res Ther; 2015; 11(4):1029. PubMed ID: 26881609
[TBL] [Abstract][Full Text] [Related]
5. Primary thyroid osteosarcoma: staging and evaluation of response to therapy with F-18 FDG PET-CT.
Makis W; Novales-Diaz JA; Hickeson M
Clin Nucl Med; 2010 Jul; 35(7):517-20. PubMed ID: 20548146
[No Abstract] [Full Text] [Related]
6. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
[TBL] [Abstract][Full Text] [Related]
7. Interesting image. Unsuspected synchronous thyroid carcinoma revealed on a post-therapy F-18 FDG PET/CT, in a patient with follicular lymphoma.
Makis W; Hickeson M; Novales-Diaz JA
Clin Nucl Med; 2010 Nov; 35(11):879-81. PubMed ID: 20940548
[No Abstract] [Full Text] [Related]
8. Imaging in endocrinology: 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up.
Salvatori M; Biondi B; Rufini V
Eur J Endocrinol; 2015 Sep; 173(3):R115-30. PubMed ID: 25947140
[TBL] [Abstract][Full Text] [Related]
9. PET imaging for response assessment in lymphoma: potential and limitations.
Schöder H; Moskowitz C
Radiol Clin North Am; 2008 Mar; 46(2):225-41, viii. PubMed ID: 18619378
[TBL] [Abstract][Full Text] [Related]
10. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
[TBL] [Abstract][Full Text] [Related]
11. F-18 FDG PET/CT imaging of a subcutaneous scalp metastasis from primary carcinoma of the thyroid.
Niederkohr RD; Dadras SS; Leavitt M; McDougall IR
Clin Nucl Med; 2007 Feb; 32(2):162-4. PubMed ID: 17242580
[No Abstract] [Full Text] [Related]
12. Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT.
Wang R; Zhu H; Chen Y; Li C; Li F; Shen Z; Tian J; Yu L; Xu B
Hematol Oncol; 2014 Sep; 32(3):126-32. PubMed ID: 23996464
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of lymphoma presenting as asymmetrically increased testicular activity on FDG-PET/CT.
Kuo PH; Cooper DL; Cheng DW
Semin Nucl Med; 2006 Jan; 36(1):105-7. PubMed ID: 16356799
[No Abstract] [Full Text] [Related]
14. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.
Specht L
Semin Radiat Oncol; 2007 Jul; 17(3):190-7. PubMed ID: 17591566
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG PET of thyroid nodules with inconclusive cytologic results.
Martínez-Duncker C; Hurtado-López LM
J Nucl Med; 2006 Sep; 47(9):1555; author reply 1555-6. PubMed ID: 16954566
[No Abstract] [Full Text] [Related]
16. The management of pyothorax-associated lymphoma using 18F-FDG PET/CT.
Ito K; Shida Y; Kubota K; Morooka M; Aruga T; Itami J; Matsuda H
Ann Nucl Med; 2010 Nov; 24(9):649-54. PubMed ID: 20740330
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET for a thyroid MALT lymphoma.
Lee CJ; Hsu CH; Tai CJ; Lin SE
Acta Oncol; 2008; 47(6):1165-7. PubMed ID: 18770065
[No Abstract] [Full Text] [Related]
18. Metastatic malignant melanoma to the thyroid gland detected by FDG-PET imaging.
Basu S; Alavi A
Clin Nucl Med; 2007 May; 32(5):388-9. PubMed ID: 17452870
[No Abstract] [Full Text] [Related]
19. Detection of thyroid metastases from nasopharyngeal carcinoma with F-18 FDG PET/CT.
Osmany S; Padhy AK; Ng DC
Clin Nucl Med; 2008 Mar; 33(3):224-5. PubMed ID: 18287855
[No Abstract] [Full Text] [Related]
20. Tumour thrombus in the superior vena cava from anaplastic carcinoma of the thyroid: FDG-PET/CT imaging findings.
Strobel K; Steinert HC; Bhure U; Koma AY; Gassmann N; Stöckli SJ
Eur J Nucl Med Mol Imaging; 2007 May; 34(5):813. PubMed ID: 17225114
[No Abstract] [Full Text] [Related]
[Next] [New Search]
